We recently published a list of  Why These 15 Big-Cap Stocks Are Plunging So Far in 2025. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other big-cap stocks that are plunging so far in 2025.

The market has been reversing its gains earlier in the year, so much so that the S&P 500 is now down 1.5% year-to-date. The past two years have seen the same index post stellar gains back-to-back, and those gains were mostly spearheaded by big-cap stocks.

However, historically speaking, the market delivering a third year of such returns would be unprecedented. Investors believe that 2025 will likely be a year when the market starts to cool off, and recent events have started a trend toward just that.

Big-cap stocks are now leading the way down as tariff and AI-related fears hurt them the most. Many big-cap companies have invested significantly in these tech trends, which investors have now soured on.

Still, it’s a good idea to keep an eye on the big-cap losers year-to-date. Many of them have declined enough to open up buying opportunities.

Methodology

For this article, I screened the worst-performing big-cap stocks year-to-date.

I will also mention the number of hedge fund investors in these stocks. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

A healthcare professional in a lab coat holding a microscope and looking at a slide under the lens.

Danaher Corporation (NYSE:DHR)

Number of Hedge Fund Holders In Q4 2024: 101

Danaher Corporation (NYSE:DHR) is a diversified company that makes medical, industrial, and commercial products. It mostly focuses on life sciences and biotechnology.

The stock is down significantly so far in 2025 as Danaher missed its Q4 2024 EPS target by 5.5%. It reported $5.29 instead of the expected $5.57.

Revenue for the quarter was $6.54 billion, which was above expectations but slower than that of Danaher’s peers. Analysts lowered their expectations for all of 2025 following the report and now project only 1.1% revenue growth.

Not only that, Danaher itself projected a low-single-digit contraction in non-GAAP core revenue for Q1 2025 compared to the prior year period. It also faces risks in its China market.

The consensus price target of $278 implies 35% upside.

Danaher Corporation (NYSE:DHR) stock is down 10.30% year-to-date.

Overall, DHR ranks 11th on our list of big-cap stocks that are plunging so far in 2025. While we acknowledge the potential of DHR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than DHR but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

 

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

 

Disclosure: None. This article is originally published at Insider Monkey.